Are Reduced Reimbursement and Avoidable Complications

Putting Your Bottom Line at Risk?

Having a comprehensive cardiovascular profile available to the treating physician allows early intervention that can improve outcome; but if done invasively it is also associated with increased patient risk. Hospitals are very interested in preventing hospital acquired conditions (HACs). Insurers are increasingly withholding payments for HACs such as: air embolism and infections that are associated with catheter insertions to obtain vascular access.

PhysioFlow® provides the diagnostic benefit without patient risk, has lower disposable costs and is reimbursable under APC codes. It is consistent with reimbursement policies that encourage care of heart failure (HF) patients in the outpatient setting. The Financial Template (shown below) contrasts the cost-effectiveness of the inpatient vs. outpatient CMS's reimbursement situation.

Using PhysioFlow®  improves diagnosis and helps staff maximize cost-efficiency at the point of entry. In the Y-Model, developed by Sieck & Associates, one can see the balance between quality and cost for the ADHF population.